Dr. Michael L Hawthorne, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 855 Belanger St, Suite 208, Houma, LA 70360 Phone: 985-872-6210 Fax: 985-876-7743 |
Dr. Ugochukwu Dennis Sunday Ezema, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8166 Main St, Houma, LA 70360 Phone: 985-873-4141 |
Dr. Ralph James Bourgeois, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 855 Belanger St, Suite 107, Houma, LA 70360 Phone: 985-581-0059 Fax: 985-851-0156 |
Carlos Ernesto Viteri-yaquian, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1990 Industrial Blvd, Houma, LA 70363 Phone: 203-997-5207 |
Andrea G Espinoza, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1990 Industrial Blvd, Houma, LA 70363 Phone: 985-868-9300 Fax: 985-851-0053 |
Dr. Andrea Rudomin Conant Lorio, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8120 Main Street, Suite 204, Houma, LA 70360 Phone: 985-850-6090 Fax: 985-850-6099 |
News Archive
A "low-carb, mixed-carb" sports drink with added protein leads to prolonged endurance performance in trained female athletes, according to a study in the April issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Many experts believe a milestone has been reached with the issuing of guidelines for pharmaceutical companies to encourage them to gather and submit information about how genetic variations affect the way people respond to their drugs.
Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.
As the popularity of fitness trackers has increased, so have the opportunities to use such devices to not only track fitness goals but also increase the motivation to meet those goals.
ViroPharma Incorporated today announced that it has entered into an exclusive option to acquire Meritage Pharma, Inc., a private company based in San Diego, CA focused on developing oral budesonide suspension (OBS) as a treatment for eosinophilic esophagitis (EoE), a chronic inflammatory disorder of the esophagus.
› Verified 4 days ago